# RTW Biotech Opportunities Ltd USD (RTW)

**Page:** https://fundology.uk/fund/rtw · ISIN GG00BKTRRM22

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, RTW (RTW Biotech Opportunities Ltd USD, ISIN GG00BKTRRM22) closed at $2.44 on the London Stock Exchange. Over the five years to 13/11/2026 its price changed by +31.0% (income paid out is not included), or +2.3% after UK CPIH inflation.

## Summary

RTW Biotech Opportunities Ltd USD is an investment trust. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Latest close: **$2.44** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | RTW |
| ISIN | GG00BKTRRM22 |
| Category | Investment trusts |
| Type | Investment trust |
| Domicile | Guernsey |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +35.22% | +30.43% | price only |
| 3 years | +103.05% | +83.45% | price only |
| 5 years | +31.03% | +2.27% | price only |

Returns: worked out from recorded daily closes. Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of RTW Biotech Opportunities Ltd USD in pounds (price only, income paid out not included): 2022 −23.8%, 2023 +9.6%, 2024 +5.2%, 2025 +39.1%; 2026 to 13/11/2026 +14.3%. Returns of RTW Biotech Opportunities Ltd USD in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +55.4%; to 30/09/2025: +1.5%; to 30/09/2024: +13.6%; to 30/09/2023: −3.2%; to 30/09/2022: −27.5%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -23.8% | -30.3% | Price |
| 2023 | +9.6% | +5.3% | Price |
| 2024 | +5.2% | +1.6% | Price |
| 2025 | +39.1% | +34.3% | Price |
| 2026 to 13/11/2026 | +14.3% | +10.6% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 23.77% | -13.86% |
| 3 years | 22.76% | -35.36% |
| 5 years | 27.28% | -43.35% |

## Largest fall

Volatility of RTW Biotech Opportunities Ltd USD in pounds, annualised from weekly returns to 13/11/2026: 23.8% over 1 year, 22.8% over 3 years, 27.3% over 5 years. Largest fall in the price of RTW Biotech Opportunities Ltd USD since November 2021, in pounds: −39.6% from 31/12/2021 to 07/04/2023. The lowest 12-month return of RTW Biotech Opportunities Ltd USD in pounds (price only, income paid out not included) since January 2021 was −46.2% (12 months to 01/07/2022); the highest was +106.0% (12 months to 03/07/2026). On 13/11/2026 the price of RTW Biotech Opportunities Ltd USD was 3.2% below its highest weekly close since November 2021 (14/08/2026), in pounds.

## Charges & eligibility

- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## Questions people ask

**What is the ISIN of RTW?**

The ISIN of RTW is GG00BKTRRM22. An ISIN identifies one exact share class of a fund; RTW is its ticker on the London Stock Exchange.

**What were RTW’s returns in each of the last five years?**

Calendar-year returns of RTW in pounds (price only, income paid out not included): 2022 −23.8%, 2023 +9.6%, 2024 +5.2%, 2025 +39.1%; 2026 to 13/11/2026 +14.3%. Past performance is not a guide to future returns.

**How has RTW done after inflation?**

Over the five years to 13/11/2026 RTW’s price changed by +31.0% (income paid out is not included), or +2.3% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.